Latest Period
Q1 2026
Security Snapshot
Guardian Pharmacy Services, Inc. - CLASS A COMMON STOCK (GRDN) Institutional Ownership
CUSIP: 40145W101
13F Institutional Holders and Ownership History from Q3 2024 to Q1 2026
Institutions Reporting
170
Shares (Excl. Options)
28,307,760
Price
$37.66
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / CLASS A COMMON STOCK
- Symbol
- GRDN on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 28,307,760
- Total 13F value
- $1,065,787,483
- Portfolio coverage rank
- 0%
- Share change
- +8,053,218
- Value change
- +$304,011,170
- Number of holders
- 170
- Shares outstanding
- 36,297,796
- SEC-reported price per share
- $36.27
- Insider filing price
- $36.27
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- GRDN - Guardian Pharmacy Services, Inc. - CLASS A COMMON STOCK is tracked under CUSIP 40145W101.
- 170 institutions reported positions in Q1 2026.
- 15 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 128 to 170 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $599,808,755 to $1,065,787,483.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 170 institutions filings for Q1 2026.
Security key
40145W101
Latest holder period
Q1 2026
13F holders
170
13D/G owners
15
CIK / CUSIP context first
Open Q1 2026 holders
GRDN full holder history
Guardian Pharmacy Services, Inc. SEC filings
Guardian Pharmacy Services, Inc. company facts
Guardian Pharmacy Services, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 40145W101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
15
Security
GRDN
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Bindley Capital Partners I, LLC | 21% | -4.5% | $350,077,817 | +$83,498,729 | 10,605,205 | +31% | Thomas J. Salentine, Jr. | 20 Mar 2026 |
| FMR LLC | 6.5% | $92,368,815 | 2,359,357 | FMR LLC | 31 Mar 2026 | |||
| BROWN ADVISORY INC | 4.5% | -37% | $49,485,081 | +$1,116,399 | 1,644,569 | +2.3% | BROWN ADVISORY INC | 31 Dec 2025 |
| BlackRock, Inc. | 4.2% | -25% | $45,369,761 | +$6,053,967 | 1,507,822 | +15% | BlackRock, Inc. | 31 Dec 2025 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.1% | -38% | $33,795,042 | -$619,764 | 1,123,132 | -1.8% | Wellington Management Group LLP | 31 Dec 2025 |
| FRANKLIN RESOURCES INC | 4.3% | -46% | $19,914,623 | +$4,847,652 | 976,207 | +32% | Franklin Resources, Inc. | 30 Jun 2025 |
| VANGUARD GROUP INC | 4.2% | -32% | $20,602,636 | +$7,853,289 | 966,806 | +62% | The Vanguard Group | 30 Jun 2025 |
| J. Goldman & Co LP | 2.9% | -66% | $17,229,438 | -$2,471,496 | 656,860 | -13% | J. Goldman & Co LP | 30 Sep 2025 |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 2.1% | $11,531,175 | 467,986 | TIAA-CREF Investment Management, LLC | 30 May 2025 | |||
| Clearbridge Investments, LLC | 2% | -60% | $9,088,690 | -$1,332,446 | 445,524 | -13% | Clearbridge Investments, LLC | 30 Jun 2025 |
| Alyeska Investment Group, L.P. | 4.7% | $10,328,537 | 428,570 | Alyeska Investment Group, L.P. | 31 Dec 2024 | |||
| Woodline Partners LP | 4.5% | $10,004,392 | 415,120 | Woodline Partners LP | 31 Dec 2024 | |||
| Ophir Asset Management Pty Ltd | 1.8% | $4,041,401 | 167,693 | Ophir Asset Management Pty Ltd | 05 Dec 2024 | |||
| Nuveen Asset Management, LLC | 0.31% | $1,707,848 | 69,312 | Nuveen Asset Management, LLC | 30 May 2025 | |||
| TEACHERS ADVISORS, LLC | 0.05% | $257,266 | 10,441 | Teachers Advisors, LLC | 30 May 2025 |
As of 31 Mar 2026, 170 institutional investors reported holding 28,307,760 shares of Guardian Pharmacy Services, Inc. - CLASS A COMMON STOCK (GRDN). This represents 78% of the company’s total 36,297,796 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
62%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 6.5% | 2,359,357 | +129678% | 0% | $88,853,373 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.9% | 1,765,119 | +57% | 0.01% | $66,474,382 |
| BlackRock, Inc. | 4.8% | 1,756,374 | +0.78% | 0% | $66,145,045 |
| Woodline Partners LP | 3.6% | 1,306,318 | +24% | 0.19% | $49,195,936 |
| BROWN ADVISORY INC | 3.5% | 1,259,174 | -23% | 0.08% | $47,420,496 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 1,225,543 | 0% | 0% | $46,153,949 |
| Valiant Capital Management, L.P. | 3.3% | 1,186,658 | -3.7% | 3.5% | $44,689,540 |
| TimesSquare Capital Management, LLC | 3% | 1,077,474 | +2.8% | 0.69% | $40,577,671 |
| T. Rowe Price Investment Management, Inc. | 2.8% | 1,028,389 | 0.03% | $38,730,000 | |
| Boston Partners | 2.8% | 1,017,683 | -3.5% | 0.04% | $38,396,633 |
| FRANKLIN RESOURCES INC | 2.6% | 952,952 | -3.9% | 0.01% | $35,888,172 |
| LOOMIS SAYLES & CO L P | 2.6% | 931,689 | +47% | 0.05% | $35,087,407 |
| JENNISON ASSOCIATES LLC | 2.3% | 822,784 | +610% | 0.02% | $30,986,046 |
| BOONE CAPITAL MANAGEMENT LLC | 1.7% | 631,193 | 7.3% | $23,770,728 | |
| Driehaus Capital Management LLC | 1.6% | 589,121 | +16% | 0.16% | $22,186,297 |
| CITADEL ADVISORS LLC | 1.6% | 579,121 | 0.02% | $21,809,697 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5% | 559,035 | +14% | 0% | $21,056,997 |
| Nuveen, LLC | 1.5% | 537,451 | -16% | 0.01% | $20,240,404 |
| STATE STREET CORP | 1.4% | 509,018 | +11% | 0% | $19,169,618 |
| Aristotle Capital Boston, LLC | 1.4% | 495,856 | -16% | 1.2% | $18,673,937 |
| MARSHALL WACE, LLP | 1.2% | 417,710 | 0.02% | $15,730,961 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 1% | 374,946 | -51% | 0.1% | $14,120,466 |
| SEI INVESTMENTS CO | 0.99% | 358,181 | +40% | 0.01% | $13,489,110 |
| TWO SIGMA INVESTMENTS, LP | 0.86% | 312,675 | +109% | 0.01% | $11,775,340 |
| Alyeska Investment Group, L.P. | 0.76% | 275,000 | 0.03% | $10,356,500 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Latest
Q1 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 28,307,760 | $1,065,787,483 | +$304,011,170 | $37.66 | 170 |
| 2025 Q4 | 19,929,056 | $599,808,755 | +$12,941,766 | $30.09 | 128 |
| 2025 Q3 | 19,660,592 | $515,161,278 | +$38,705,240 | $26.23 | 111 |
| 2025 Q2 | 18,189,989 | $387,569,002 | +$181,272,786 | $21.31 | 105 |
| 2025 Q1 | 9,779,825 | $207,873,021 | +$4,351,060 | $21.26 | 74 |
| 2024 Q4 | 9,588,383 | $194,142,574 | +$28,373,850 | $20.26 | 68 |
| 2024 Q3 | 8,424,469 | $141,704,040 | +$141,704,040 | $16.80 | 51 |